Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum

INTRODUCTION: The biological pathways involved in the preclinical stage of the Alzheimer's continuum are not well understood. METHODS: We used NeuroToolKit and Elecsys(®) immunoassays to measure cerebrospinal fluid (CSF) amyloid‐β (Aβ)42, Aβ40, phosphorylated tau (p‐tau), total tau (t‐tau), neu...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Alzheimers Dement
Auteurs principaux: Milà‐Alomà, Marta, Salvadó, Gemma, Gispert, Juan Domingo, Vilor‐Tejedor, Natalia, Grau‐Rivera, Oriol, Sala‐Vila, Aleix, Sánchez‐Benavides, Gonzalo, Arenaza‐Urquijo, Eider M., Crous‐Bou, Marta, González‐de‐Echávarri, José Maria, Minguillon, Carolina, Fauria, Karine, Simon, Maryline, Kollmorgen, Gwendlyn, Zetterberg, Henrik, Blennow, Kaj, Suárez‐Calvet, Marc, Molinuevo, José Luis
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Featured Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7586814/
https://ncbi.nlm.nih.gov/pubmed/32573951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/alz.12131
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires